바로가기메뉴

본문 바로가기 주메뉴 바로가기
 
 

logo

  • ENGLISH
  • P-ISSN3022-6805
  • E-ISSN3022-6791
  • KCI

ISSN : 3022-6805

논문 상세

다음
논문 투고

Vol.13 No.14

PDF Citation Share

Cognitive Improvement Effect of Resplex Alpha A in the Scopolamine-induced Mouse Model

셀메드 / CELLMED, (P)3022-6805; (E)3022-6791
2023, v.13 no.14, pp.1-1
https://doi.org/10.5667/CellMed.2023.014
장봉근 (JBK-LAB, Inc.)
권영선 (JBK-LAB, Inc.)
박선영 (JBK-LAB, Inc.)
이건우 (JBK-LAB, Inc.)
강혜연 (JBK-LAB, Inc.)
김점용 (JBK-LAB, Inc.)
장봉근, 권영선, 박선영, 이건우, 강혜연, & 김점용. (2023). . , 13(14), 1-1, https://doi.org/10.5667/CellMed.2023.014

Abstract

Administration of Scopolamine can be considered a psychopharmacological model of Alzheimer's disease (AD). We made an animal model of Alzheimer's disease (AD) by administering Scopolamine to Blab/c mice. In this study, we investigated the effects of Resplex Alpha on memory impairment and cognitive function in mice in a mouse animal model of Scopolamine-induced memory impairment. Through Y-mazed and passive avoidance behavioral assays, we observed that Resplex Alpha recovered Scopolamine-induced short-term memory and cognitive functions. The results of our study imply that Resplex Alpha may be beneficial in the prevention of Alzheimer's disease (AD).

keywords
Resveratrol-alginate nano-complex (RANCP), Ginkgo biloba extract (EGb231), Cognitive function, Memory dysfunction, Alzheimer’s disease (AD), dementia

셀메드

논문 투고 OA 정책